Why the study?
Does LDL reactivity with arterial proteoglycans discriminate young male survivors of myocardial infarction from healthy controls?
Does LDL reactivity with arterial proteoglycans discriminate young male survivors of myocardial infarction from healthy controls?
LDL reactivity with arterial proteoglycans is a highly significant, independent factor that discriminates young male survivors of myocardial infarction from healthy controls.
Answers are grounded in this paper and cite their sources.
LDL reactivity may aid discrimination in young male MI survivors; case-control data leave prospective validation and clinical utility open.
In the present study, the hypothesis that the affinity of LDL to arterial proteoglycans might discriminate myocardial infarction patients from controls were tested. The patients were 52 men who had sustained a myocardial infarction at an age of 50 years or less and the controls, selected from a random population sample, were matched to the patients for age and sex. Serum cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol and apoB discriminated patients from controls. In addition, LDL reactivity with arterial proteoglycans was significantly higher in patients than in controls. In a multiple regression analysis, with patient or control as the dependent variable, apoB levels, LDL proteoglycan reactivity and serum triglycerides appeared as independent contributors to the regression. These observations indicate that LDL reactivity with arterial proteoglycans is a new, highly significant factor which discriminates between young myocardial infarction patients and controls.
No takes yet. Share an insight, caveat, or question.
LINDÉN et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: